Latest in Pharmaceutical

WHO pandemic agreement determined after three years of negotiation

Through the deal, WHO will promote a unified, global response to future pandemics, ensuring that national health systems are equipped to control future outbreaks

Find out more

Omron and Cognizant to offer IT/OT integration services to pharmaceutical manufacturers

Together, Omron and Cognizant will help manufacturers to integrate IT-OT into their operations and maintenance processes
See more

Kyowa Kirin opens drug substance manufacturing facility in Takasaki, Japan

The facility will be responsible for the production of biopharmaceutical drug substances, as well as the training of employees

Pfizer discontinues development of GLP-1 receptor agonist, danuglipron

The oral GLP-1 receptor agonist was discontinued due to reports of potential drug-induced liver toxicity in one patient during phase III trials

CDMO PharmaLogic acquires majority stake in Agilera Pharma

By acquiring a majority stake in Agilera, PharmaLogic will bolster its global presence in the promising radiopharmaceutical manufacturing field
You need to be a subscriber to read this article.
Click here to find out more.

Top reasons to rent product inspection systems

For manufacturers facing production challenges, renting product inspection systems can be a cost-effective and flexible solution

Trump's tariffs: an expert's take on pharmaceutical impact, where to go from here

To discuss the potential implications of pharmaceutical tariffs on the industry and how companies should approach these changes, MC spoke with AvaTrade’s Chief Market Analyst, Kate Leaman

Lonza and Ethris team up to develop mRNA vaccines for respiratory diseases

The two hope to produce a temperature-stable mRNA vaccine for influenza, which may promote mucosal immunity through its nasal delivery system

Weight loss drugs fuelling rapid big pharma growth, report reveals

Weight loss and diabetes medications are championing growth in key big pharma players, such as Novo Nordisk and Eli Lilly

Preparing for the future of contained oncology drug production

Advancements in oncology drug production, containment technologies, and automation have manifestly improved the safety, efficiency, and precision aspects of manufacturing highly potent cancer treatments

Latest posts in Pharmaceutical

AstraZeneca puts $2.5bn into Chinese R&D and manufacturing capabilities

The pharmaceutical giant will establish its sixth strategic R&D centre in China, as well as novel research and manufacturing agreements in the region

Servier to develop and commercialise targeted solid tumour therapy, BDTX-4933

Through a worldwide licensing agreement, Servier will commercialise Black Diamond Therapeutics' targeted small molecule therapeutic for patinets with RAF/RAS-mutant solid tumours

Orphan drug sales will continue to rise, 2025 Evaluate report notes

The 2025 Orphan Drug Report notes that orphan drugs will likely make $320bn by 2030, with Johnson & Johnson taking $31.7bn of this
You need to be a subscriber to read this article.
Click here to find out more.

Navigating ESG challenges in pharma and logistics: the road to sustainability

Jake Brown, Commercial Lead at LogiPharma, discusses the upcoming 25th edition of the conference and how some of its key sponsors are navigating ESG challenges

Orion to open new biologics R&D centre in Cambridge, UK, in 2025

Biologics are the fastest growing segment in pharma, representing huge opportunities for new innovative treatments
You need to be a subscriber to read this article.
Click here to find out more.

Preserving pharmaceutical potency with temperature mapping

Maintaining a stable temperature in pharmacy refrigerators is crucial to preserve the integrity and efficacy of their contents. Many pharmaceuticals are extremely sensitive to temperature fluctuations and slight deviations can impact drug potencies, rendering them ineffective or even harmful to patients

Teva Pharmaceuticals identifies risk to European medicine supply security in new research

The generic drug manufacturer warns that the European supply chain of critical generic medicines is not diversified, relying on a select few companies to distribute oncology, cardiology, antibiotic and mental health therapeutics

Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar

FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel

Johnson & Johnson to bolster neuroscience portfolio with $14.6bn Intra-Cellular Therapies acquisition

Through this potential acquisition, Johnson & Johnson will add schizophrenia and bipolar drug Caplyta to its portfolio, as well as a range of clinical candidates designed to treat neurological diseases

Boehringer Ingelheim ramps up its oncology ADC development with new tech and antigen target

The company has licensed Lonza-owned Synaffix's ADC platform technology, while also claiming the rights to a fourth novel oncology target from an ongoing discovery partnership with Oxford BioTherapeutics

Gaelic Laboratories expands its reach into the Middle East with new commercial subsidiary

The European pharmaceutical CMO now has access to the Middle Eastern market, while also being capable of getting its partners into the lucrative market

Neuraxpharm bolsters its CNS-targeting therapeutic range with narcolepsy drugs Nuvigil and Provigil

By acquiring Teva Pharmaceutical's Nuvigil and Provigil, Neuraxpharm hopes to enhance its narcolepsy offering, while also expanding its global presence

Sponsor content

How to replace old mindsets with a quality mindset

Replace old mindsets with a quality focused mindset to get better results in pharma operations. How? Read this article to find out more

Aenova expands with new gummy line for pharma and food grade

Aenova is implementing a new gummy line at its site in Cornu, Romania

Logistics4Pharma expands customs offerings to include storage and transit management

Logistics4Pharma, a Frankfurt-based GDP-certified pharma logistics provider, has expanded its service portfolio

CDMO services and innovative products for pharmaceutical industry

The Italian company stands as a reliable partner for pharmaceutical and biotech clients in the Japanese market

How you can improve quality and efficiency with internal audits

This article looks at how your company can improve both quality and efficiency by conducting effective internal audits

Berry to showcase its healthcare capabilities at Maghreb Pharma

Berry Global’s presence at this year’s Maghreb Pharma Expo highlights the company’s commitment to supporting growth in emerging healthcare markets across North Africa

The carrot and the stick: revitalising quality in the pharmaceutical industry

The pharmaceutical sector is at a critical juncture, facing immense pressure to enhance quality management systems and ensure the safety of medications

Nova Laboratories: a leader in aseptic processing

Our client, Nova Laboratories, is a leading CDMO based in Leicestershire, UK, specialising in the aseptic processing of pharmaceutical, biopharmaceutical, and medical...

Improve your pharmaceutical operation by implementing simplification and behaviour change

How you can improve pharmaceutical plant operations using three simplification strategies to increase efficiency and reduce errors

Opportunities in a transformative market

A new era of pharmaceutical regulations and business in the Middle East

Key advantages of vacuum tray drying

Vacuum tray drying is a tried-and-trusted method in critical industries, like biotech and pharmaceutical manufacturing. It lends itself to high-throughput, batch-drying...

Registration opens for INTERPHEX 2025

April 1-3 in NYC Learning Lab conference schedule, show floor content, and new features announced

Featured companies

3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support...
See more